Prognostic value of alpha-fetoprotein radioimmunoassay in surgically treated patients with embryonal cell carcinoma of the testis.
Alpha-fetoprotein was assayed radioimmunologically in 51 samples of sera from 26 patients who had been operated for embryonal cell carcinoma of the testis. The test was found to have good prognostic value. Elevated levels were seen frequently in patients with metastase or who developed metastases. The kinetic study of alpha-fetoprotein allows us to monitor treatment efficiency, as well as to study cancer evolution.